1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LIGAND PHARMACEUTICALS, INC. - ORDINARY SHARES - CLASS B

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

XNAS: LGND

Expensive Performer
Download real time

108.15 -1.26 (-1.15%)

59.70% Gain from 52W Low

224.7K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
7S
7W
0O
2T
167.1

Operating Revenue TTM

Below industry Median
-4

Net profit TTM

Negative Net profit TTM
-2.4

Net Profit Margin TTM %

27.3

Operating Revenue growth TTM %

Below industry Median
-107.7

Net Profit TTM Growth %

Negative Net Profit TTM Growth %

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history